Protocol Ledger

NCT04867317 · Phase III · RECRUITING

Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)

Interventional Phase III clinical trial protocol NCT04867317 sponsored by VA Office of Research and Development in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-01-13 Enrollment: 172 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04867317
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)172 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)0 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04867317
Protocol FieldVerified Registry Value
NCT IdentifierNCT04867317
Consolidated Lead SponsorVA Office of Research and Development
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment172 participants (ESTIMATED)
Registered Start Date2025-01-13
WhyStopped ClassificationNot Stopped

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI